LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple attack on tough bile duct cancer
Disease control Not yet recruitingThis study is testing a new three-drug combination for people with advanced bile duct cancer that has a specific marker called HER2. The goal is to see if the combination can shrink tumors and control the disease. About 65 participants will receive the treatment, and researchers …
Matched conditions: LENVATINIB
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
AI scans tissue slides to predict which liver cancer treatments will work
Diagnosis Not yet recruitingThis study is developing an artificial intelligence (AI) tool to help doctors choose the best treatment for patients after liver cancer surgery. The AI analyzes standard digital images of a patient's tumor tissue to predict whether they are likely to benefit from specific follow-…
Matched conditions: LENVATINIB
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC